Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9H255
UPID:
O51E2_HUMAN
Alternative names:
HPRAJ; Olfactory receptor OR11-16; Prostate-specific G-protein coupled receptor
Alternative UPACC:
Q9H255; B2RA63; Q6IF94
Background:
Olfactory receptor 51E2, also known as HPRAJ and Prostate-specific G-protein coupled receptor, is a pivotal protein activated by various substances including beta-ionone, short-chain fatty acids, and possibly steroid hormones. It plays a crucial role in processes such as melanocyte proliferation, melanogenesis, and the regulation of blood pressure through renin secretion. Its activation by L-lactate in glomus cells suggests a broad spectrum of physiological functions.
Therapeutic significance:
Understanding the role of Olfactory receptor 51E2 could open doors to potential therapeutic strategies. Its involvement in cell proliferation, migration, and melanogenesis, alongside its potential role in blood pressure regulation, highlights its significance in developing treatments for related disorders.